{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T16:26:27Z","timestamp":1787415987331,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ejca.2026.116943","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T05:51:59Z","timestamp":1783921919000},"page":"116943","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Treatment considerations in patients with metastatic pancreatic cancer who did not receive systemic therapy: A population-based study"],"prefix":"10.1016","volume":"245","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-1992-4065","authenticated-orcid":false,"given":"Thijmen H.T.","family":"Broekman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara M.","family":"Mackay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"de Vos-Geelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8712-9825","authenticated-orcid":false,"given":"Geert A.","family":"Cirkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merlijn U.J.E.","family":"Graus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Willem B.","family":"de Groot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjolein Y.V.","family":"Homs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9298-2878","authenticated-orcid":false,"given":"Saskia A.C.","family":"Luelmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonie J.M.","family":"Mekenkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirte M.","family":"Streppel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rogier P.","family":"Voermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam L.","family":"Wumkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc G.","family":"Besselink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1637-5520","authenticated-orcid":false,"given":"Lydia G.","family":"van der Geest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna W.","family":"Wilmink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ejca.2026.116943_bib1","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1001\/jamasurg.2023.7872","article-title":"Implementation of best practices in pancreatic cancer care in the netherlands: a stepped-wedge randomized clinical trial","volume":"159","author":"Mackay","year":"2024","journal-title":"JAMA Surg"},{"issue":"1","key":"10.1016\/j.ejca.2026.116943_bib2","doi-asserted-by":"crossref","first-page":"4444","DOI":"10.1038\/s41598-020-61487-0","article-title":"Surgery for synchronous and metachronous single-organ metastasis of pancreatic cancer: a SEER database analysis and systematic literature review","volume":"10","author":"Liu","year":"2020","journal-title":"Sci Rep"},{"issue":"19","key":"10.1016\/j.ejca.2026.116943_bib3","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","article-title":"FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer","volume":"364","author":"Conroy","year":"2011","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.ejca.2026.116943_bib4","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","article-title":"Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine","volume":"369","author":"Hoff","year":"2013","journal-title":"N Engl J Med"},{"issue":"31","key":"10.1016\/j.ejca.2026.116943_bib5","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1200\/JCO-25-00436","article-title":"PASS-01: randomized phase II trial of modified FOLFIRINOX versus gemcitabine\/nab-paclitaxel and molecular correlatives for previously untreated metastatic pancreatic cancer","volume":"43","author":"Knox","year":"2025","journal-title":"J Clin Oncol J Am Soc Clin Oncol"},{"issue":"8","key":"10.1016\/j.ejca.2026.116943_bib6","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1634\/theoncologist.2016-0447","article-title":"Patterns of chemotherapy use in a U.S.-based cohort of patients with metastatic pancreatic cancer","volume":"22","author":"Abrams","year":"2017","journal-title":"Oncologist"},{"issue":"22","key":"10.1016\/j.ejca.2026.116943_bib7","doi-asserted-by":"crossref","first-page":"8480","DOI":"10.1002\/cam4.3477","article-title":"Reducing nihilism in metastatic pancreatic ductal adenocarcinoma: Treatment, sequencing, and effects on survival outcomes","volume":"9","author":"O\u2019Reilly","year":"2020","journal-title":"Cancer Med"},{"issue":"9","key":"10.1016\/j.ejca.2026.116943_bib8","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1111\/ans.15721","article-title":"Population-based analysis of treatment patterns and outcomes for pancreas cancer in Victoria","volume":"90","author":"Pilgrim","year":"2020","journal-title":"ANZ J Surg"},{"issue":"6","key":"10.1016\/j.ejca.2026.116943_bib9","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1080\/0284186X.2020.1725241","article-title":"Implementation of contemporary chemotherapy for patients with metastatic pancreatic ductal adenocarcinoma: a population-based analysis","volume":"59","author":"Latenstein","year":"2020","journal-title":"Acta Oncol"},{"issue":"9","key":"10.1016\/j.ejca.2026.116943_bib10","first-page":"825","article-title":"Factors impacting informed decision-making for patients with pancreatic cancer: a qualitative study","volume":"33","author":"Quinn","year":"2025","journal-title":"Support Care Cancer J Multinatl Assoc Support Care Cancer"},{"issue":"4","key":"10.1016\/j.ejca.2026.116943_bib11","first-page":"1375","article-title":"What determines the timing of discussions on forgoing anticancer treatment? A national survey of medical oncologists","volume":"27","author":"Mori","year":"2019","journal-title":"Support Care Cancer J Multinatl Assoc Support Care Cancer"},{"issue":"2","key":"10.1016\/j.ejca.2026.116943_bib12","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3390\/curroncol33020116","article-title":"Characteristics, prognosis and reasons for opting-out of treatment in patients with untreated pancreatic cancer","volume":"33","author":"Ladekarl","year":"2026","journal-title":"Curr Oncol"},{"issue":"9","key":"10.1016\/j.ejca.2026.116943_bib13","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1080\/0284186X.2018.1470330","article-title":"Patient characteristics and treatment considerations in pancreatic cancer: a population based study in the Netherlands","volume":"57","author":"Zijlstra","year":"2018","journal-title":"Acta Oncol"},{"issue":"8","key":"10.1016\/j.ejca.2026.116943_bib14","doi-asserted-by":"crossref","first-page":"W163","DOI":"10.7326\/0003-4819-147-8-200710160-00010-w1","article-title":"Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration","volume":"147","author":"Vandenbroucke","year":"2007","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.ejca.2026.116943_bib15","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1097\/SLA.0000000000003779","article-title":"Establishing and coordinating a nationwide multidisciplinary study group: lessons learned by the dutch pancreatic cancer group","volume":"271","author":"Strijker","year":"2020","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejca.2026.116943_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v045.i03","article-title":"mice: multivariate imputation by chained equations in R","volume":"45","author":"Buuren","year":"2011","journal-title":"J Stat Softw"},{"issue":"1","key":"10.1016\/j.ejca.2026.116943_bib17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12874-025-02481-w","article-title":"Propensity score matching: should we use it in designing observational studies?","volume":"25","author":"Wan","year":"2025","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"10.1016\/j.ejca.2026.116943_bib18","doi-asserted-by":"crossref","first-page":"9993","DOI":"10.1038\/s41467-024-54444-2","article-title":"An umbrella review of socioeconomic status and cancer","volume":"15","author":"Li","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.ejca.2026.116943_bib19","article-title":"Socioeconomic disparities in treatment and survival of oesophageal and gastric cancer in the Netherlands: a nationwide population-based study","volume":"65","author":"van der Aa","year":"2026","journal-title":"Lancet Reg Health Eur"},{"issue":"3","key":"10.1016\/j.ejca.2026.116943_bib20","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3109\/0284186X.2014.953257","article-title":"Ten weeks to live: a population-based study on treatment and survival of patients with metastatic pancreatic cancer in the south of the Netherlands","volume":"54","author":"Bernards","year":"2015","journal-title":"Acta Oncol"},{"issue":"18","key":"10.1016\/j.ejca.2026.116943_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.71248","article-title":"Trends in the treatment and survival of pancreatic cancer: analysis of 23,339 patients diagnosed between 2010 and 2017","volume":"14","author":"Damm","year":"2025","journal-title":"Cancer Med"},{"issue":"12","key":"10.1016\/j.ejca.2026.116943_bib22","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1002\/ijc.31628","article-title":"Nonsurgical therapies for resected and unresected pancreatic cancer in Europe and USA in 2003\u20132014: a large international population-based study","volume":"143","author":"Huang","year":"2018","journal-title":"Int J Cancer"},{"issue":"10","key":"10.1016\/j.ejca.2026.116943_bib23","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1002\/cam4.3011","article-title":"Treatment patterns and outcomes in pancreatic cancer: retrospective claims analysis","volume":"9","author":"Doleh","year":"2020","journal-title":"Cancer Med"},{"issue":"4","key":"10.1016\/j.ejca.2026.116943_bib24","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/ajco.12862","article-title":"Chemotherapy in patients with unresected pancreatic cancer in Australia: a population-based study of uptake and survival","volume":"14","author":"Dumbrava","year":"2018","journal-title":"Asia Pac J Clin Oncol"},{"key":"10.1016\/j.ejca.2026.116943_bib25","author":"National Cancer Autit Collaborating Centre","year":"2024","journal-title":"Natl Pancreat Cancer Audit State Nation Report 2024"},{"key":"10.1016\/j.ejca.2026.116943_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.103068","article-title":"Longitudinal health-related quality of life in patients with pancreatic cancer stratified by treatment: a nationwide cohort study","volume":"80","author":"Gehrels","year":"2025","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.ejca.2026.116943_bib27","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.critrevonc.2016.01.006","article-title":"Does chemotherapy improve health-related quality of life in advanced pancreatic cancer? A systematic review","volume":"99","author":"Kristensen","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ejca.2026.116943_bib28","unstructured":"Over deze keuzehulp - Alvleesklierkanker keuzehulp. Accessed May 2, 2026. https:\/\/ak.keuzehulp.nl\/over-keuzehulp."},{"issue":"6","key":"10.1016\/j.ejca.2026.116943_bib29","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-047376","article-title":"Cancer aging research group (CARG) score in older adults undergoing curative intent chemotherapy: a prospective cohort study","volume":"11","author":"Ostwal","year":"2021","journal-title":"BMJ Open"},{"issue":"9","key":"10.1016\/j.ejca.2026.116943_bib30","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.6004\/jnccn.2020.7669","article-title":"SOURCE-PANC: a prediction model for patients with metastatic pancreatic ductal adenocarcinoma based on nationwide population-based data","volume":"19","author":"Boorn","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.ejca.2026.116943_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2026.116263","article-title":"Comparing short- and long-term survivors in metastatic pancreatic cancer: Insights into patient and disease profiles impacting systemic therapy outcomes","volume":"236","author":"Graus","year":"2026","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2026.116943_bib32","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1743-7563.2012.01522.x","article-title":"Importance of health literacy in oncology","volume":"8","author":"Koay","year":"2012","journal-title":"Asia Pac J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2026.116943_bib33","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/s44276-025-00187-6","article-title":"Cancer care disparities among patients with limited English proficiency: challenges and strategies for equity","volume":"3","author":"Kim","year":"2025","journal-title":"BJC Rep"},{"issue":"5","key":"10.1016\/j.ejca.2026.116943_bib34","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1002\/ijc.70145","article-title":"Increased incidence, survival, and registration quality of primary hepato-pancreato-biliary cancers in the Netherlands Cancer Registry","volume":"158","author":"van der Geest","year":"2026","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2026.116943_bib35","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12904-025-01657-x","article-title":"Development of specialist palliative care in Dutch hospitals between 2014 and 2020: a repeated survey","volume":"24","author":"van Velzen","year":"2025","journal-title":"BMC Palliat Care"},{"issue":"3","key":"10.1016\/j.ejca.2026.116943_bib36","doi-asserted-by":"crossref","first-page":"6","DOI":"10.5334\/ijic.7504","article-title":"Potentially inappropriate end of life care and healthcare costs in the last 30 days of life in regions providing integrated palliative care in the Netherlands: a registration-based study","volume":"24","author":"Pereira","year":"2024","journal-title":"Int J Integr Care"},{"issue":"7-8","key":"10.1016\/j.ejca.2026.116943_bib37","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/ans.18906","article-title":"Best supportive care in advanced pancreas cancer: a systematic review to define a patient-care bundle","volume":"94","author":"Law","year":"2024","journal-title":"ANZ J Surg"},{"issue":"12","key":"10.1016\/j.ejca.2026.116943_bib38","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1080\/0284186X.2023.2273898","article-title":"Timing of start of systemic treatment in patients with asymptomatic metastasized pancreatic cancer (TIMEPAN): a protocol of a multicenter prospective patient preference non-randomized trial","volume":"62","author":"Augustinus","year":"2023","journal-title":"Acta Oncol"},{"issue":"10","key":"10.1016\/j.ejca.2026.116943_bib39","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S2468-1253(24)00197-3","article-title":"Alternating gemcitabine plus nab-paclitaxel and gemcitabine alone versus continuous gemcitabine plus nab-paclitaxel after induction treatment of metastatic pancreatic cancer (ALPACA): a multicentre, randomised, open-label, phase 2 trial","volume":"9","author":"Dorman","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.ejca.2026.116943_bib40","doi-asserted-by":"crossref","first-page":"8666","DOI":"10.1038\/s41598-018-26811-9","article-title":"The benefits of modified FOLFIRINOX for advanced pancreatic cancer and its induced adverse events: a systematic review and meta-analysis","volume":"8","author":"Tong","year":"2018","journal-title":"Sci Rep"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804926007240?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804926007240?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T16:18:57Z","timestamp":1787415537000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804926007240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":40,"alternative-id":["S0959804926007240"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2026.116943","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment considerations in patients with metastatic pancreatic cancer who did not receive systemic therapy: A population-based study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2026.116943","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"116943"}}